Geroscience Translational Clinical Trials Conference (GTCT)

22 March 2023

The Geroscience Translational Clinical Trials Conference (GTCT) is scheduled for March 22, 2023 in Toulouse, France right before the start of the International Conference on Frailty and Sarcopenia Research 2023 (ICFSR23) on March 22-24, 2023

The Geroscience Translational & Clinical Trials Conference (GTCT) will bring together international leaders from academia, clinical practice, industry and regulatory agencies all working towards the development of new drugs targeting age-related diseases to maintain functions and achieve independent and healthy aging.

The different sessions will give priority to randomized controlled trials (RCTs) and studies on improving and accelerating RCTs on translational and clinical geroscience including methods, statistical models, endpoint definition and validation, biomarkers, drugs targets. The conference will also address preclinical and mechanistic studies, as well as clinical trials on animal models and humans. Pharmacological (e.g. senolytics, NAD+, m-Tor inhibitors, metformin…) and non-pharmacological interventions (diet, physical exercise, fasting, …) will be highlighted in the different sessions.

This is the opportunity for key actors around the world to network and form collaborations to work towards the same goal to speed up the development of effective therapeutics to promote healthy longevity.

On behalf of the Scientific Committee

The ERNs are co-funded by the
European Union (Health Programme and CEF)

EU Commission

“EURO-NMD is one of the 24 European Reference Networks (ERNs) approved by the ERN Board of Member States. The ERNs are co-funded by the European Union (Health Programme and CEF).
For more information about the ERNs and the EU health strategy,
please visit